Legal status · United Kingdom
Is Lorecivivint legal in the United Kingdom?
No. Lorecivivint is not approved for any medical use in the United Kingdom; its classification is "Investigational, not licensed". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.
Lorecivivint in the United Kingdom at a glance
| Classification | Investigational, not licensed |
|---|---|
| MHRA approval status | Not approved by MHRA; investigational |
| Evidence level | Moderate (research strength: Strong) |
| Reviewed | Sep 2026 |
Classification and note come from the Lorecivivint profile, checked against Medicines and Healthcare products Regulatory Agency (MHRA) listings at the reviewed date.
What this means
- 01
Lorecivivint is being studied in registered clinical trials but has not received MHRA marketing approval in the United Kingdom.
- 02
Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.
- 03
Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.
What Lorecivivint is
An injected Wnt-pathway small molecule for knee osteoarthritis, given once or twice a year, with an NDA submitted to the FDA in January 2026 after multi-year cartilage-preservation data.
Lorecivivint inhibits CLK and DYRK1A kinases to modulate Wnt signaling in the joint, aiming to slow cartilage loss rather than only relieve pain. After a mixed Phase 3 history, Biosplice's long-term OA-07 data showed preservation of joint-space width over several years, and the company submitted a New Drug Application on January 6, 2026.
Mechanism: Intra-articular CLK/DYRK1A inhibition that modulates Wnt signaling, reducing inflammation and promoting chondrocyte health.
Regulatory history: NDA under FDA review (submitted January 2026)
How MHRA treats this kind of product
Licenses medicines for the UK market. A compound without a marketing authorisation is an unlicensed medicine, which can only lawfully be supplied for human use through a prescriber under the specials scheme, not sold as a research product.
The classification above is the The Longevity Archive reading of Medicines and Healthcare products Regulatory Agency listings for Lorecivivint at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Lorecivivint in other countries
Frequently asked questions
Is Lorecivivint legal in the United Kingdom?
No. Lorecivivint is not approved for any medical use in the United Kingdom; its classification is "Investigational, not licensed". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.
Can I buy Lorecivivint in the United Kingdom?
No approved product exists to buy. In the United Kingdom Lorecivivint is classified as "Investigational, not licensed", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is Lorecivivint MHRA approved?
No. In the United Kingdom Lorecivivint is classified as "Investigational, not licensed", which is not a MHRA marketing approval. For comparison, the US FDA status is: NDA under FDA review (submitted January 2026). Evidence level: Moderate.
Related compounds in the United Kingdom
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Lorecivivint live on its compound profile.
Lorecivivint profileThis page is general information about the regulatory status of Lorecivivint in the United Kingdom, current as of Sep 2026. It is not legal advice, and classifications change; check Medicines and Healthcare products Regulatory Agency directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.